Sara Hurvitz
MD
Professor and Medical Director of Clinical Research
👥Biography 个人简介
Sara Hurvitz is a leading clinical investigator in HER2-positive breast cancer focused on neoadjuvant and advanced disease settings. She has contributed to landmark trials of trastuzumab deruxtecan (T-DXd) and tucatinib in HER2+ advanced breast cancer. Her research examines how pathologic complete response in neoadjuvant settings predicts long-term survival and guides adjuvant treatment decisions. She has also studied HER2-low breast cancer as an emerging therapeutic subtype.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Sara Hurvitz 的研究动态
Follow Sara Hurvitz's research updates
留下邮箱，当我们发布与 Sara Hurvitz（University of Washington / Fred Hutchinson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment